Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2003
04/15/2003US6546929 Dry powder dispersing apparatus and methods for their use
04/15/2003CA2190007C Antitumor indolopyrrolocarbazole derivatives
04/11/2003WO2002030934A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines
04/11/2003CA2425685A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines
04/10/2003WO2003029363A1 Water-color ink
04/10/2003WO2003029252A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
04/10/2003WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents
04/10/2003WO2003029228A1 Novel method of preparing nitrogen macrocycles
04/10/2003WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
04/10/2003WO2003029209A2 Chemical compounds
04/10/2003WO2003028734A1 Triazepine derivatives as neurotrophic agents
04/10/2003WO2003028733A1 Tetracyclic indole derivatives as 5-ht receptor ligands
04/10/2003WO2003028732A1 Receptor antagonist
04/10/2003WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
04/10/2003WO2003028725A1 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands
04/10/2003WO2003028629A2 Chlorin photosensitizing agents for use in photodynamic therapy
04/10/2003WO2003028628A2 Photosensitizing carbamate derivatives
04/10/2003WO2003004493A8 Novel compounds, their preparation and use
04/10/2003WO2002102793A3 Quinazolinediones as antibacterial agents
04/10/2003WO2002094830A8 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069422 Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
04/10/2003US20030069416 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069296 Central nervous system disorders
04/10/2003US20030069290 Substituted-heteroaryl-7-aza[2.2.1] bycycloheptanes for the treatment of desease
04/10/2003US20030069281 Controlling concentration of cellular oxidizer; antiinflammatory agents, autoimmune disease, anticancer agents
04/10/2003US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid
04/10/2003US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
04/10/2003US20030069248 Antiinflammatory agents; controlling cell cycle
04/10/2003US20030069247 Explosives; pyrotechnics; cyclization of dicyandiamide with hydrazine hydrochloride
04/10/2003US20030069246 Central nervous system disorders; psychological disorders; cardiovascular disorders
04/10/2003US20030069244 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
04/10/2003US20030069237 Nitrogen containing heterobicycles as factor Xa inhibitors
04/10/2003US20030069230 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
04/10/2003US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462643A1 Triazepine derivatives as neurotrophic agents
04/10/2003CA2462508A1 Photosensitizing carbamate derivatives
04/10/2003CA2462261A1 Chlorin photosensitizing agents for use in photodynamic therapy
04/10/2003CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents
04/10/2003CA2461344A1 Novel method of preparing nitrogen macrocycles
04/10/2003CA2453343A1 Tetracyclic indole derivatives as 5-ht receptor ligands
04/10/2003CA2430328A1 Receptor antagonist
04/09/2003EP1300398A1 Propane-1,3-dione derivatives
04/09/2003EP1300159A1 Remedies for cancer
04/09/2003EP1299398A1 Methods and kits for the detection of arginine compounds
04/09/2003EP1299390A1 Novel triazolo pyrimidine compounds
04/09/2003EP1299389A1 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
04/09/2003EP1299388A1 Variolin derivatives as anti-cancer agents
04/09/2003EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function
04/09/2003EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives
04/09/2003EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase
04/09/2003EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use
04/09/2003EP1149101B1 4-OXO-3,5-DIHYDRO-4$i(H)-PYRIDAZINO 4,5-$i(b)]INDOLE-1-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE
04/09/2003EP1058711B1 Bicyclooctane derivatives as plasticisers
04/09/2003EP0915875B1 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
04/09/2003CN1409713A Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
04/09/2003CN1409712A Pyrrolo [2,3-d] pyrimidine compounds
04/09/2003CN1408713A Heterocyclic compound 2-aminoimidazopyrrole-6-one and its preparing method and use
04/09/2003CN1105109C Chloropyrimide intermediates
04/08/2003US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
04/08/2003US6545071 Stabilizer mixtures
04/08/2003US6545032 Synthesis of [3,5,7]-H-imidazo[1,5-a] imidazol-2(3H)-one compounds
04/08/2003US6545013 2,7-naphthyridine derivatives
04/08/2003US6545000 [1,2,4]triazolo[1,5-c]pyrimidine derivatives
04/08/2003US6544999 Use as a sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent, and especially used for the treatment of insomnia.
04/08/2003US6544995 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein
04/08/2003US6544988 Tyrosine kinase inhibitors
04/08/2003US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation
04/08/2003US6544983 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
04/08/2003US6544979 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
04/08/2003US6544977 Crystalline forms of 1s-[1-alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl)carbonyl]amino]octahydro-6h-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide
04/08/2003US6544975 Mimetics that inhibit lipid peroxidation; for use in the treatment of diseases or disorders mediated by oxidative stress, such as asthma, inflammatory bowel disease, arthritis and vasculitis.
04/08/2003US6544724 Coupler and silver halide color photographic light-sensitive material
04/08/2003US6544701 Reaction product, process for the production thereof, electrophotographic photoconductor using the reaction product, electrophotographic apparatus using the photoconductor, and process cartridge for electrophotographic apparatus
04/08/2003CA2112165C Bicyclic amine derivatives
04/03/2003WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003WO2003027116A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
04/03/2003WO2003027115A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
04/03/2003WO2003027110A2 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones
04/03/2003WO2003027067A2 Process for making carbapenem compounds
04/03/2003WO2003027066A2 Methods of making porphyrins and related compounds with lewis acid
04/03/2003WO2003026646A1 Photodynamic porphyrin antimicrobial agents
04/03/2003WO2003000269A3 Novel use for pde 10a inhibitors
04/03/2003WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7
04/03/2003WO2002026267A3 Manganes complexes for magnetic resonance imaging
04/03/2003US20030065219 Cyclization of an alcohol containing urea compound
04/03/2003US20030065179 Diabetic therapy
04/03/2003US20030065128 Low absorption, low double refraction; for use as the core and cladding layers in optical thin film devices (electrooptics)
04/03/2003US20030065066 Ortho-hydroxyphenyl substituted triazine compounds bonded to aminoplast resins; increased compatibility with coating resin and have reduced volatility due to higher molecular weights resulting from anchoring
04/03/2003US20030065007 Analgesics; psychological disorders; antidepressants
04/03/2003US20030064993 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
04/03/2003US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/03/2003US20030064990 Sexual disorders therapy; antiallergens; respiratory system disorders
04/03/2003US20030064984 Anticancer agents; side effect reduction
04/03/2003US20030064982 Pyrazole compounds useful as protein kinase inhibitors
04/03/2003US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease
04/03/2003US20030064962 Protease inhibitor; viricide
04/03/2003US20030064332 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound